## PODD: Insulet Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -7.0% below STRENGTH zone (4.0-10.0%); PEG 2.19 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($273.80)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Insulet expands pod recycling program to all U.S. customers**
- Source: Investing.com India | 20251215T130250 | Bullish | Relevance: 100%
- Insulet Corporation has expanded its Pod recycling program nationwide to all U.S. customers after successful pilot initiatives. The program allows users of its tubeless insulin pump technology to return used Pods for recycling at no cost, furthering the company's environmental initiatives. Insulet (NASDAQ:PODD) maintains strong financial performance, with analysts issuing upward revisions for upcoming earnings expectations.

**2. Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future**
- Source: Yahoo Finance | 20251215T120850 | Bullish | Relevance: 100%
- Insulet Corporation has expanded its Omnipod® U.S. recycling program to all U.S. customers, aiming to divert millions of Pods from landfills. This expansion follows successful pilots in Massachusetts and California, complementing existing takeback programs in other countries. Customers can request a free recycling kit to return used Pods, which are then decontaminated and sent to recycling specialists, supporting Insulet's commitment to sustainability and circular solutions.

**3. Insulet expands Pod recycling program nationwide across US**
- Source: StreetInsider | 20251215T120446 | Bullish | Relevance: 100%
- Insulet Corporation has expanded its Omnipod Pod recycling program to all U.S. customers, following successful pilot programs in Massachusetts and California. This initiative allows users to request free recycling kits for their used Pods, which are then decontaminated and processed at a specialized facility. The program aims to reduce landfill waste and supports Insulet's sustainability goals.

**4. Munro Partners Purchases Shares of 14,355 Insulet Corporation $PODD**
- Source: MarketBeat | 20251214T132321 | Somewhat-Bullish | Relevance: 100%
- Munro Partners has acquired a new stake of 14,355 shares in Insulet Corporation, valued at approximately $4.51 million, during the second quarter. Insulet (NASDAQ:PODD) has a "Moderate Buy" consensus rating from analysts, with an average target price of $379.65. The company recently reported quarterly earnings of $1.24 per share, beating estimates by $0.11, while revenue of $521.7 million missed consensus but grew 29.9% year-over-year.

**5. Engineers Gate Manager LP Acquires 96,272 Shares of Insulet Corporation $PODD**
- Source: MarketBeat | 20251213T110820 | Bullish | Relevance: 100%
- Engineers Gate Manager LP significantly increased its stake in Insulet Corporation (NASDAQ:PODD) by 1,798.5% in Q2, acquiring 96,272 additional shares to hold a total of 101,625 shares valued at approximately $31.93 million. This comes as other institutional investors and hedge funds also adjusted their holdings in the medical instruments supplier, and analysts maintain a "Moderate Buy" consensus with an average price target of $379.65. Insulet recently beat Q1 earnings expectations, reporting a 29.9% revenue increase compared to the previous year.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-24 | Canaccord Genui | $432 | $428 | +1% |
| 2025-11-21 | Truist Securiti | $412 | $390 | +6% |
| 2025-11-21 | RBC Capital | $380 | $370 | +3% |
| 2025-11-21 | BTIG | $380 | $370 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-24 | Canaccord Genui | main | Buy |
| 2025-11-21 | Truist Securiti | main | Buy |
| 2025-11-21 | RBC Capital | main | Outperform |
| 2025-11-21 | BTIG | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($0.30M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+1.0%)
- FMR, LLC: 10.8% (+0.8%)
- Blackrock Inc.: 9.4% (+2.8%)
- Capital Research Glo: 6.5% (-4.0%)
- State Street Corpora: 4.4% (+1.1%)

### Key Risks

1. Premium valuation (P/E 48x, PEG 2.2x) vulnerable to multiple compression.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 5 raises (avg +5%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 2.19 elevated, pricing in significant growth expectations. Balance sheet: strong liquidity (2.9x). Revenue growth strong at 20% YoY. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.8B |
| Beta | 1.38 |
| 52W Range | $230.05 - $354.88 |
| Short Interest | 4.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.19 |
| Forward P/E | 47.9 |
| Current P/E | 60.4 |
| YoY Growth | 26.2% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -10.3% to -7.0% (+3.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 11.0pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.6%) - potential reversal signal. AM_20 at -6.5% indicates price below own 20MA trend. Underperforming sector by 6.7pp, stock-specific weakness. Below SMA200 (0.98x), long-term trend not supportive. MACD histogram bearish (-3.02), momentum weakening. OFD pattern: -DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -6.99% (CS: 4) | Weak |
| RSI_14 | 38.4 | Neutral |
| MACD Histogram | -3.02 | Bearish |
| vs SMA20 | 0.935x | Below |
| vs SMA50 | 0.928x | Below |
| vs SMA200 | 0.982x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $295.70
- **Stop Loss:** $273.80 (7.4% risk)
- **Target:** $317.60 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 45
- **Position Value:** $13,306.50
- **Portfolio %:** 13.31%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-19 (Est: $1.46)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.15 | $1.24 | +8.1% |
| 2025Q2 | $0.92 | $1.17 | +26.8% |
| 2025Q1 | $0.79 | $1.02 | +29.7% |
| 2024Q4 | $1.02 | $1.15 | +12.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*